Skip to main content

COVID-19 Topic Center

Video

Video
Tom Kraus, vice president of government relations, ASHP, discusses the recent Department of Health and Human Services (HHS) announcement that allows inactive pharmacists along with pharmacy interns to join the vaccinator force—explaining that as the vaccine supply increases, these additional…
Video
Michael Ganio, PharmD, senior director of Pharmacy Practice and Quality, ASHP, breaks down the importance of centralized leadership and clear onsite roles within mass COVID-19 vaccine locations, highlighting the pitfalls that should be avoided during the setup of these sites and how to prevent…
Video
Gary Kerr, PharmD, MBA, chief pharmacy officer, Baystate Health, and president of HOSP, discusses a recent open letter that the Health System Owned Speciality Pharmacy Alliance wrote to better address the challenges that many speciality pharmacies face, and explains what he hopes clinical…
Video
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Video
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and decision-making processes in pharmacy, and why it is…
Video
Eric Maroyka, PharmD, senior director, Center for Pharmacy Practice Advancement, ASHP, discusses the recent announcement from Pfizer regarding a successful COVID-19 vaccine, reviews the logistics of the vaccine, and highlights future challenges other vaccine trials may face that are currently…
Video
Andrea Russo, MD, director, Electrophysiology and Arrhythmia Services, Cooper Hospital, discusses why there have been delays among patients making primary care visits, along with the impact this has on diagnosis, and she provides tips for health care providers—such as pharmacists that might be…
Video
Tom Knight, CEO, Invistics, discusses the challenges that drug diversion programs address, why these programs are important during the pandemic, and offers tips for health care professionals who are looking to implement these programs into practice.
Video
Tasha Polster, vice president, pharmacy, quality, compliance and patient safety, Walgreens, discusses the measures Walgreens has taken to work with manufacturers to increase flu vaccine supply, and highlights how pharmacists can encourage and educate patients on the availability of the flu vaccine.
Video
Julie Johnson, PharmD, and Oyunbileg Magvanjav, MD, PhD, discuss the results of their recent study that explores the relationship between prescribing rates of guideline-recommended antihypertensive drug classes and blood pressure control.
Back to Top